Uncategorized

Health Canada clarifies position on Platelet Rich Plasma treatments

Posted on

OTTAWA – In follow up to Health Canada’s communication on unauthorized stem cell therapies on May 15, 2019, Health Canada would like to clarify for patients and practitioners that Platelet Rich Plasma (PRP) treatments, including Platelet Rich Fibrin treatments, are not the same as cell therapies and, as a result, are not subject to Health Canada’s Policy Position Paper on Autologous Cell Therapy Products.

Uncategorized

Laser-based medical devices not authorized to treat fungal nail infections

Posted on

Last updated: 2019-07-25 For immediate release OTTAWA – Health Canada is advising Canadians that laser-based medical devices are not authorized to treat fungal nail infections (onychomycosis). Health Canada is aware that certain clinics, spas, and vendors are promoting laser-based medical devices to treat fungal nail infections. Canadians may be putting their health at risk if […]

Uncategorized

Pfizer Canada is reporting a shortage of EpiPen (0.3 mg) auto-injectors and taking precautions to minimize impact on Canadians

Posted on

Last updated: 2019-07-19 July 19, 2019For immediate release OTTAWA – Pfizer Canada is reporting that, while there has been stable supply of EpiPen auto-injectors in Canada in 2019 to date, a shortage of its 0.3 mg format EpiPen auto-injector may lead to temporary supply constraints in the coming months. EpiPen Jr (0.15 mg) is not […]

Uncategorized

KHN’s ‘What The Health?’: Biden Doubles Down On Obamacare

Posted on

Presidential candidate Joe Biden unveiled a health plan intended to provide a more moderate alternative to his competitors’ “Medicare for All” plans. It would build on the Affordable Care Act but would go much further. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss this, plus Planned Parenthood’s very bad week, the U.S. House vote to repeal the health law’s “Cadillac tax” on generous health plans, and the reduction in deaths from opioids.